Infra-slow EEG neurofeedback for insomnia: a single-case experimental study in primary care.
Some participants reported better sleep after training, but responses varied. Improvements partly moved back toward baseline at three months, and wearable sleep measurements showed limited agreement.
Edvardsson A, Smith MG, Rolstad SE, Steingrimsson S, Enriquez-Geppert S, Balt K, Landahl J, Weineland S.
Frontiers in human neuroscience · Publication date: 2026-07-16
Added to site: 2026-09-09
DOI: 10.3389/fnhum.2026.1832178
Publication date recorded by Europe PMC; online and issue dates may differ.
- Modalities
- Neurofeedback, ISF
- Clinical focus
- Insomnia
- Population
- Primary-care patients with insomnia and related comorbidities
- Sample
- 10 enrolled; 9 completed; 8 analyzed
- Intervention / method
- Two-week baseline followed by 12 weekly individualized ISF sessions
- Comparator
- Within-person baseline; no external control group
Clinician summary
Five of eight analyzed participants had significant Tau-U changes in subjective sleep quality. Group PSQI and PHQ-9 scores improved post-treatment, with partial reversal at follow-up.
How to interpret the findings
Very small uncontrolled series with heterogeneous responses. Feasibility and preliminary symptom changes do not establish efficacy.
Equipment and disclosures
Equipment details were not verified from the reviewed abstract.
Funding and competing-interest disclosures were not verified from the reviewed abstract.
An August 21, 2026 correction removed an erroneously added institutional affiliation. The correction does not report a change to study findings.
Read the correction ↗Related evidence
Compare findings from the same clinical area, including mixed results.
- Infra-low frequency neurofeedback impact on post-concussive symptoms of headache, insomnia and attention disorder: Results of a randomized control trial. · Positive with limitations
- Personalizing sleep therapy: Integrating EEG neurofeedback into the sleep disorders management. · Positive with limitations
- Transcranial photobiomodulation to enhance sleep by elevating adenosine signaling: a translational study. · Positive with limitations
Summary prepared with AI assistance. Source verification does not imply an independent replication or a clinician's endorsement. Read our review method.